Published on in Vol 6, No 3 (2019): March

Preprints (earlier versions) of this paper are available at, first published .
Technological Interventions for Medication Adherence in Adult Mental Health and Substance Use Disorders: A Systematic Review

Technological Interventions for Medication Adherence in Adult Mental Health and Substance Use Disorders: A Systematic Review

Technological Interventions for Medication Adherence in Adult Mental Health and Substance Use Disorders: A Systematic Review


  1. D'Arcey J, Collaton J, Kozloff N, Voineskos A, Kidd S, Foussias G. The Use of Text Messaging to Improve Clinical Engagement for Individuals With Psychosis: Systematic Review. JMIR Mental Health 2020;7(4):e16993 View
  2. Haga S. Toward digital-based interventions for medication adherence and safety. Expert Opinion on Drug Safety 2020;19(6):735 View
  3. Sua Y, Jiang Y, Thompson D, Wang W. Effectiveness of mobile phone-based self-management interventions for medication adherence and change in blood pressure in patients with coronary heart disease: A systematic review and meta-analysis. European Journal of Cardiovascular Nursing 2020;19(3):192 View
  4. Flore J. Ingestible sensors, data, and pharmaceuticals: Subjectivity in the era of digital mental health. New Media & Society 2021;23(7):2034 View
  5. Greenway K, Garel N, Jerome L, Feduccia A. Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. Expert Review of Clinical Pharmacology 2020;13(6):655 View
  6. García-Pérez L, Linertová R, Serrano-Pérez P, Trujillo-Martín M, Rodríguez-Rodríguez L, Valcárcel-Nazco C, del Pino-Sedeño T. Interventions to improve medication adherence in mental health: the update of a systematic review of cost-effectiveness. International Journal of Psychiatry in Clinical Practice 2020;24(4):416 View
  7. Watson T, Schindel T, Simpson S, Hughes C. Medication adherence in patients with mental illness and recent homelessness: contributing factors and perceptions on mobile technology use. International Journal of Pharmacy Practice 2020;28(4):362 View
  8. Shire S, Baker Worthman L, Shih W, Kasari C. Comparison of Face-to-Face and Remote Support for Interventionists Learning to Deliver JASPER Intervention with Children Who have Autism. Journal of Behavioral Education 2020;29(2):317 View
  9. Alipour A, Gabrielson S, Patel P. Ingestible Sensors and Medication Adherence: Focus on Use in Serious Mental Illness. Pharmacy 2020;8(2):103 View
  10. Brubaker J, Beverly E. Burnout, Perceived Stress, Sleep Quality, and Smartphone Use: A Survey of Osteopathic Medical Students. Journal of Osteopathic Medicine 2020;120(1):6 View
  11. Marrero R, Fumero A, de Miguel A, Peñate W. Psychological factors involved in psychopharmacological medication adherence in mental health patients: A systematic review. Patient Education and Counseling 2020;103(10):2116 View
  12. Schramm Z, Leroux B, Radick A, Ventura A, Klein J, Samet J, Saxon A, Kim T, Tsui J. Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial. Addiction Science & Clinical Practice 2020;15(1) View
  13. Minen M, Corner S, Berk T, Levitan V, Friedman S, Adhikari S, Seng E. Heartrate variability biofeedback for migraine using a smartphone application and sensor: A randomized controlled trial. General Hospital Psychiatry 2021;69:41 View
  14. Shetty K, Chen A, Rose A, Liu H. Effect of the ExactCare medication care management model on adherence, health care utilization, and costs. Journal of Managed Care & Specialty Pharmacy 2021;27(5):574 View
  15. Mokwena K, Ngoveni A. Challenges of Providing Home Care for a Family Member with Serious Chronic Mental Illness: A Qualitative Enquiry. International Journal of Environmental Research and Public Health 2020;17(22):8440 View
  16. Serrano‐Ripoll M, Ricci‐Cabello I, Jiménez R, Zamanillo‐Campos R, Yañez‐Juan A, Bennasar‐Veny M, Sitges C, Gervilla E, Leiva A, García‐Campayo J, García‐Buades M, García‐Toro M, Pastor‐Moreno G, Ruiz‐Perez I, Alonso‐Coello P, Llobera J, Fiol‐deRoque M. Effect of a mobile‐based intervention on mental health in frontline healthcare workers against COVID‐19: Protocol for a randomized controlled trial. Journal of Advanced Nursing 2021;77(6):2898 View
  17. Donelan C, Hayes E, Potee R, Schwartz L, Evans E. COVID-19 and treating incarcerated populations for opioid use disorder. Journal of Substance Abuse Treatment 2021;124:108216 View
  18. McGeary D, McGeary C. Telerehabilitation for Headache Management. Physical Medicine and Rehabilitation Clinics of North America 2021;32(2):373 View
  19. Fowler J, Cope N, Knights J, Fang H, Skubiak T, Shergill S, Phiri P, Rathod S, Peters-Strickland T. Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis. Neuropsychiatric Disease and Treatment 2021;Volume 17:483 View
  20. Benville J, Compton P, Giordano N, Cheatle M. Perceived social support in patients with chronic pain with and without opioid use disorder and role of medication for opioid use disorder. Drug and Alcohol Dependence 2021;221:108619 View
  21. Chai P, Bustamante M, Goodman G, Mohamed Y, Najarro J, Sullivan M, Castillo-Mancilla J, Coyle R, Mayer K, Rosen R, Baumgartner S, Alpert P, Boyer E, O'Cleirigh C. A Brief Training Program to Support the Use of a Digital Pill System for Medication Adherence: Pilot Descriptive Study. JMIR Formative Research 2021;5(4):e26213 View
  22. Dawoodbhoy F, Delaney J, Cecula P, Yu J, Peacock I, Tan J, Cox B. AI in patient flow: applications of artificial intelligence to improve patient flow in NHS acute mental health inpatient units. Heliyon 2021;7(5):e06993 View
  23. Fiol-DeRoque M, Serrano-Ripoll M, Jiménez R, Zamanillo-Campos R, Yáñez-Juan A, Bennasar-Veny M, Leiva A, Gervilla E, García-Buades M, García-Toro M, Alonso-Coello P, Pastor-Moreno G, Ruiz-Pérez I, Sitges C, García-Campayo J, Llobera-Cánaves J, Ricci-Cabello I. A Mobile Phone–Based Intervention to Reduce Mental Health Problems in Health Care Workers During the COVID-19 Pandemic (PsyCovidApp): Randomized Controlled Trial. JMIR mHealth and uHealth 2021;9(5):e27039 View
  24. Kang A, Walton M, Hoadley A, DelaCuesta C, Hurley L, Martin R. Patient Experiences with the Transition to Telephone Counseling during the COVID-19 Pandemic. Healthcare 2021;9(6):663 View
  25. Watts M, Murphy E, Keogh B, Downes C, Doyle L, Higgins A. Deciding to discontinue prescribed psychotropic medication: A qualitative study of service users’ experiences. International Journal of Mental Health Nursing 2021;30(S1):1395 View
  26. Roth C, Papassotiropoulos A, Brühl A, Lang U, Huber C. Psychiatry in the Digital Age: A Blessing or a Curse?. International Journal of Environmental Research and Public Health 2021;18(16):8302 View
  27. Saad A, Bruno D, Camara B, D’Agostino J, Bolea-Alamanac B. Self-directed Technology-Based Therapeutic Methods for Adult Patients Receiving Mental Health Services: Systematic Review. JMIR Mental Health 2021;8(11):e27404 View
  28. Rangu N, Frank-Pearce S, Alexander A, Hébert E, Ra C, Kendzor D, Businelle M. Non-adherence to psychiatric medication in adults experiencing homelessness is associated with incurred concussions. Frontiers in Human Neuroscience 2022;16 View
  29. Ongadi B, Lihana R, Kiiru J, Ngayo M, Obiero G. An Android-Based Mobile App (ARVPredictor) for the Detection of HIV Drug-Resistance Mutations and Treatment at the Point of Care: Development Study. JMIR Formative Research 2022;6(2):e26891 View
  30. Bonfiglio N, Mascia M, Penna M. Digital Treatment Paths for Substance Use Disorders (SUDs). International Journal of Environmental Research and Public Health 2022;19(12):7322 View
  31. Sweeney M, Holtyn A, Stitzer M, Gastfriend D. Practical Technology for Expanding and Improving Substance Use Disorder Treatment. Psychiatric Clinics of North America 2022;45(3):515 View
  32. Janzow G, Harding C, Flores M, Borodovsky J, Steinkamp J, Marsch L, Schuman-Olivier Z. Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial. Drug and Alcohol Dependence Reports 2022;3:100045 View
  33. Paulus M, Kuplicki R, Victor T, Yeh H, Khalsa S. Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial. BMC Psychiatry 2021;21(1) View
  34. Gonzales A, Smith S, Dullabh P, Hovey L, Heaney-Huls K, Robichaud M, Boodoo R. Potential Uses of Blockchain Technology for Outcomes Research on Opioids. JMIR Medical Informatics 2021;9(8):e16293 View
  35. Singhal P, Dhaliwal N, Dabas A, Yadav S. Optimizing Internet Use during Adolescence: eHealth Solutions. Annals of the National Academy of Medical Sciences (India) 2022;58(04):175 View
  36. Faisal S, Ivo J, Abu Fadaleh S, Patel T. Exploring the Value of Real-Time Medication Adherence Monitoring: A Qualitative Study. Pharmacy 2023;11(1):18 View
  37. Thorpe D, Strobel J, Bidargaddi N. Examining clinician choice to follow-up (or not) on automated notifications of medication non-adherence by clinical decision support systems. BMC Medical Informatics and Decision Making 2023;23(1) View
  38. Simon E, Edwards A, Sajatovic M, Jain N, Montoya J, Levin J. Systematic Literature Review of Text Messaging Interventions to Promote Medication Adherence Among People With Serious Mental Illness. Psychiatric Services 2022;73(10):1153 View
  39. Dacosta‐Sánchez D, González‐Ponce B, Fernández‐Calderón F, Sánchez‐García M, Lozano O. Retention in treatment and therapeutic adherence: How are these associated with therapeutic success? An analysis using real‐world data. International Journal of Methods in Psychiatric Research 2022;31(4) View
  40. Khan N, Stergiou G, Omboni S, Kario K, Renna N, Chapman N, McManus R, Williams B, Parati G, Konradi A, Islam S, Itoh H, Mooi C, Green B, Cho M, Tomaszewski M. Virtual management of hypertension: lessons from the COVID-19 pandemic–International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. Journal of Hypertension 2022;40(8):1435 View
  41. Taub S, Krivoy A, Whiskey E, Shergill S. New approaches to antipsychotic medication adherence – safety, tolerability and acceptability. Expert Opinion on Drug Safety 2022;21(4):517 View
  42. Zhou W, Xiao S, Feng C, Yu Y, Wang D, Hu C, Liu X. Measuring the quality of mental health services from the patient perspective in China: psychometric evaluation of the Chinese version of the World Health Organization responsiveness performance questionnaire. Global Health Action 2022;15(1) View
  43. Cochran J, Fang H, Sonnenberg J, Cohen E, Lindenmayer J, Reuteman-Fowler J. Healthcare Provider Engagement with a Novel Dashboard for Tracking Medication Ingestion: Impact on Treatment Decisions and Clinical Assessments for Adults with Schizophrenia. Neuropsychiatric Disease and Treatment 2022;Volume 18:1521 View
  44. Seamans M, Mays V, Arseniev-Koehler A, Cochran S. Prevalence of prescription and illicit drugs in suicides by non-poisoning means in the National Violent Death Reporting System 2003-2017. The American Journal of Drug and Alcohol Abuse 2022;48(4):464 View
  45. Delport A, Tabana H, Knight L, Wouters E, Chenette E. The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population groups: A scoping review protocol. PLOS ONE 2022;17(9):e0274614 View
  46. Bonfiglio N, Mascia M, Cataudella S, Penna M. Digital Help for Substance Users (SU): A Systematic Review. International Journal of Environmental Research and Public Health 2022;19(18):11309 View
  47. Dias R, Shalaby R, Agyapong B, Obuobi-Donkor G, Adu M, Eboreime E, Obeng Nkrumah S, Sridharan S, Simon P, Taylor B, Henderson N, White M, Maguire H, Gray G, Rahman F, Fair J, Wadden N, Sulyman M, Williams O, Akinkunmi O, Edem D, Arenella P, Morrison J, Awara M, Natarajan A, Nunes A, Hajek T, O’Donavan C, Uher R, Wang J, Rusak B, Wozney L, Sampalli T, Grant D, Tomblin Murphy G, Warford J, Hodder S, Boe R, Agyapong V. Augmenting Mental Health Support for Patients Accessing Different Degrees of Formal Psychiatric Care through a Supportive Text Messaging Program: Protocol for a Randomized Controlled Trial. Methods and Protocols 2023;6(1):19 View
  48. Brooklyn J, Stothart M, Stunell M, Berman V, Rylant D, Hanson M. Characterizing the Clinical use of a Novel Video-assisted Dosing Protocol With Secure Medication Dispensers to Reduce Barriers to Opioid Treatment. Journal of Addiction Medicine 2022;16(3):310 View
  49. Feng X, Luo B, Qin L. Researching on the compliance of epilepsy patients of the Phenobarbital Epilepsy Management Project in a rural area of China. Medicine 2021;100(36):e27172 View
  50. Mason M, Cho Y, Rayo J, Gong Y, Harris M, Jiang Y. Technologies for Medication Adherence Monitoring and Technology Assessment Criteria: Narrative Review. JMIR mHealth and uHealth 2022;10(3):e35157 View
  51. Li I, Hsieh W, Liu W. A Systematic Review and Meta-Analysis of the Effectiveness of Adherence Therapy and Its Treatment Duration in Patients with Schizophrenia Spectrum Disorders. Patient Preference and Adherence 2023;Volume 17:769 View
  52. Martínez-Miranda J, Meza Magallanes M, Silva-Peña C, Mercado Rivas M, Figueroa-Varela M, Sánchez Aranda M. A Computational Platform to Support the Detection, Follow-up, and Epidemiological Surveillance of Mental Health and Substance Use Disorders: Protocol for a Development and Evaluation Study. JMIR Research Protocols 2023;12:e44607 View
  53. Hadzi Boskovic D, Liang S, Parab P, Wiggins E, Liberman J. Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource Utilization. ClinicoEconomics and Outcomes Research 2023;Volume 15:487 View
  54. Miller-Rosales C, Morden N, Brunette M, Busch S, Torous J, Meara E. Provision of Digital Health Technologies for Opioid Use Disorder Treatment by US Health Care Organizations. JAMA Network Open 2023;6(7):e2323741 View
  55. Nashwan A, Gharib S, Alhadidi M, El-Ashry A, Alamgir A, Al-Hassan M, Khedr M, Dawood S, Abufarsakh B. Harnessing Artificial Intelligence: Strategies for Mental Health Nurses in Optimizing Psychiatric Patient Care. Issues in Mental Health Nursing 2023;44(10):1020 View
  56. Jan M, Coppin-Renz A, West R, Gallo C, Cochran J, Heumen E, Fahmy M, Reuteman-Fowler J. Safety Evaluation in Iterative Development of Wearable Patches for Aripiprazole Tablets With Sensor: Pooled Analysis of Clinical Trials. JMIR Formative Research 2023;7:e44768 View
  57. Ricklan S, Sohler N, Ezie C, Avalone L, Dinsell V, Lewis C, Fattal O, Balan S, McQuistion H, Pastore F, Sarcevic N, Swift R, Espejo G, Lorenz C. Impact of Telemedicine on Utilization of Psychiatric Resources in New York City during the COVID-19 Pandemic. Community Mental Health Journal 2024;60(1):115 View
  58. Gargioni L, Fogli D, Baroni P. A Systematic Review on Pill and Medication Dispensers from a Human-Centered Perspective. Journal of Healthcare Informatics Research 2024 View
  59. Walton M, Kang A, DelaCuesta C, Hoadley A, Martin R. Old tech but not low tech: telephone-based treatment provision for substance use. Frontiers in Psychiatry 2024;15 View
  60. Oveisi A, Shahabizadeh F, Bakhshani N, Shakiba M. The Effectiveness of ACT and DBT-Based Interventions with and without Exercise on Pain Outcomes and Desire for Treatment in Substance-Dependent Patients with Chronic Pain. Medical-Surgical Nursing Journal 2024;12(3) View

Books/Policy Documents

  1. Areán P, Allred R. Digital Therapeutics for Mental Health and Addiction. View
  2. Mancini A, Fabbo A. Noninvasive Mechanical Ventilation and Neuropsychiatric Disorders. View
  3. Sherer J, Richman E, Shalvoy K. Technology-Assisted Interventions for Substance Use Disorders. View
  4. Flore J. The Artefacts of Digital Mental Health. View